(Q36233590)

12 August 2017

1 reference

title

Management of hepatocellular cancer (English)

1 reference

12 August 2017

Mary F Mulcahy

1

1 reference

12 August 2017

1 September 2005

1 reference

Current Treatment Options in Oncology

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

5

1 reference

12 August 2017

423-435

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-005-0045-7

12 August 2017

0 references

cites work

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS11864-005-0045-7

Tumor ablation with radio-frequency energy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-005-0045-7

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-005-0045-7

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-005-0045-7

Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial

21 January 2018

1 reference

12 December 2020

Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules

1 reference

12 December 2020

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

1 reference

12 December 2020

Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver

1 reference

12 December 2020

Fluoropyrimidine-Radiation Interactions in Cells and Tumors

1 reference

12 December 2020

Chemoembolization of hepatocellular carcinoma

1 reference

12 December 2020

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

12 December 2020

Regulatory peptide receptors in human hepatocellular carcinomas

1 reference

12 December 2020

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma

1 reference

12 December 2020

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

12 December 2020

Role of liver transplantation in cancer therapy

1 reference

12 December 2020

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

1 reference

12 December 2020

Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma

1 reference

12 December 2020

Chemoembolization in the Management of Liver Tumors

1 reference

12 December 2020

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial

1 reference

12 December 2020

Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme)

1 reference

12 December 2020

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

12 December 2020

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

12 December 2020

Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy

1 reference

12 December 2020

Hepatobiliary surgery

1 reference

12 December 2020

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

12 December 2020

Tumor and liver drug uptake following hepatic artery and portal vein infusion

1 reference

12 December 2020

Thermal ablation therapy for hepatocellular carcinoma

1 reference

12 December 2020

A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

12 December 2020

Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).

1 reference

12 December 2020

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

1 reference

12 December 2020

Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma

1 reference

12 December 2020

Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan

1 reference

12 December 2020

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

12 December 2020

New, Effective Treatment Using Proton Irradiation for Unresectable Hepatocellular Carcinoma

1 reference

12 December 2020

Clearance of parenchymal tumors following radiotherapy: analysis of hepatocellular carcinomas treated by proton beams

1 reference

12 December 2020

A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma

1 reference

12 December 2020

Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology

1 reference

12 December 2020

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

12 December 2020

Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I-II trial

1 reference

12 December 2020

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

1 reference

12 December 2020

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

12 December 2020

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

12 December 2020

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

12 December 2020

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model

1 reference

12 December 2020

Analysis of radiation-induced liver disease using the Lyman NTCP model.

1 reference

12 December 2020

Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma

1 reference

12 December 2020

A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

Survival and intra-hepatic recurrences after laparoscopic radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis

1 reference

12 December 2020

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

1 reference

12 December 2020

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study

1 reference

12 December 2020

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

1 reference

12 December 2020

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

1 reference

12 December 2020

10.1007/S11864-005-0045-7

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16107245